Propranolol contraindications: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
mNo edit summary
Line 4: Line 4:


==Contraindications==
==Contraindications==
Propranolol is contraindicated in 1) cardiogenic shock; 2) sinus bradycardia and greater than first-degree block; 3) bronchial asthma; and 4) in patients with known hypersensitivity to propranolol hydrochloride.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = INDERAL LA (PROPRANOLOL HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [AKRIMAX PHARMACEUTICALS, LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fce692df-1e68-465e-8dda-0cb01320608c | publisher =  | date =  |accessdate = }}</ref>


==List of contraindications==
==List of contraindications==

Revision as of 22:16, 9 February 2014

Propranolol
Inderal LA® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Labels and Packages
Clinical Trials on Propranolol
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Contraindications

Propranolol is contraindicated in 1) cardiogenic shock; 2) sinus bradycardia and greater than first-degree block; 3) bronchial asthma; and 4) in patients with known hypersensitivity to propranolol hydrochloride.[1]

List of contraindications


Cardiogenic shock

Sinus bradycardia and greater than first-degree block

Bronchial asthma

Patients with known hypersensitivity to Propranolol hydrochloride



Cardiogenic shock

Return to top

Sinus bradycardia and greater than first-degree block

Return to top

Bronchial asthma

Return to top

Patients with known hypersensitivity to Propranolol hydrochloride

Return to top


References

  1. "INDERAL LA (PROPRANOLOL HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [AKRIMAX PHARMACEUTICALS, LLC]".

Adapted from the FDA Package Insert.